Large clostridial cytotoxins modifying small GTpases: Structural aspects

The Comprehensive Sourcebook of Bacterial Protein Toxins

Volumn , Issue , 2015, Pages 426-440

  Aktories, Klaus ^a   Jank, Thomas ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

ABCD model; Clostridial glycosylating toxins; Clostridium difficile; Cysteine protease; Glucosylation; Glycosyltransferase; GTP binding proteins; GTPases; Inositol hexakisphosphate (InsP6); LDL like receptor protein 1 (LRP1); N acetylglucosamine; Ras proteins; Retaining glycosyltransferases; Rho proteins; Sugar donor; Toxin binding; Toxin up take; UDP glucose

Indexed keywords

EID: 84961623874     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-800188-2.00015-X     Document Type: Chapter

References (50)

1. Stubbe H, Berdoz J, Kraehenbuhl J-P, Corthésy B Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J Immunol 2000, 164:1952-1960.
2. Krivan HC, Clark GF, Smith DF, Wilkins TD Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun 1986, 53:573-581.
3. Tucker KD, Wilkins TD Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect Immun 1991, 59:73-78.
4. Teneberg S, Lönnroth I, López JFT, Galili U, Halvarsson Mö, Ångström J, et al. Molecular mimicry in the recognition of glycosphingolipids by Gal3Gal4GlcNAc-binding Clostridium difficile toxin A, human natural anti -galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non- identical with the animal receptor. Glycobiol 1996, 6:599-609.
5. Clark GF, Krivan HC, Wilkins TD, Smith DF Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences. Arch Biochem Biophys 1987, 257:217-229.
6. Pothoulakis C, Gilbert RJ, Cladaras C, Castagliuolo I, Semenza G, Hitti Y, et al. Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J Clin Invest 1996, 98:641-649.
7. Na X, Kim H, Moyer MP, Pothoulakis C, LaMont JT gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. Infect Immun 2008, 76:2862-2871.
8. Von Eichel-Streiber C, Sauerborn M Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. Gene 1990, 96:107-113.
9. Sauerborn M, Leukel P, Von Eichel-Streiber C The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality. FEMS Microbiol Lett 1997, 155:45-54.
10. Frey SM, Wilkins TD Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect Immun 1992, 60:2488-2492.
11. Ho JG, Greco A, Rupnik M, Ng KK Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc Natl Acad Sci USA 2005, 102:18373-18378.
12. Greco A, Ho JG, Lin SJ, Palcic MM, Rupnik M, Ng KK Carbohydrate recognition by Clostridium difficile toxin A. Nat Struct Mol Biol 2006, 13:460-461.
13. Murase T, Eugenio L, Schorr M, Hussack G, Tanha J, Kitova EN, et al. Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile. J Biol Chem 2014, 289:2331-2343.
14. Fernandez-Tornero C, Lopez R, Garcia E, Gimenez-Gallego G, Romero A A novel solenoid fold in the cell wall anchoring domain of the pneumococcal virulence factor LytA. Nat Struct Biol 2001, 8:1020-1024.
15. Papatheodorou P, Zamboglou C, Genisyuerek S, Guttenberg G, Aktories K Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis. PLoS ONE 2010, 5:e10673.
16. Barth H, Pfeifer G, Hofmann F, Maier E, Benz R, Aktories K Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J Biol Chem 2001, 276:10670-10676.
17. Giesemann T, Jank T, Gerhard R, Maier E, Just I, Benz R, et al. Cholesterol-dependent pore formation of Clostridium difficile toxin A. J Biol Chem 2006, 281:10808-10815.
18. Zhang Z, Park M, Tam J, Auger A, Beilhartz GL, Lacy DB, et al. Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore. Proc Natl Acad Sci USA 2014, 111:3721-3726.
19. Genisyuerek S, Papatheodorou P, Guttenberg G, Schubert R, Benz R, Aktories K Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B. Mol Microbiol 2011, 79:1643-1654.
20. Olling A, Goy S, Hoffmann F, Tatge H, Just I, Gerhard R The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A. PLoS ONE 2011, 6:e17623.
21. Pfeifer G, Schirmer J, Leemhuis J, Busch C, Meyer DK, Aktories K, et al. Cellular uptake of Clostridium difficile toxin B: translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells. J Biol Chem 2003, 278:44535-44541.
22. Rupnik M, Pabst S, Rupnik M, Von Eichel-Streiber C, Urlaub H, Soling HD Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiol 2005, 151:199-208.
23. Reineke J, Tenzer S, Rupnik M, Koschinski A, Hasselmayer O, Schrattenholz A, et al. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 2007, 446:415-419.
24. Sheahan K-L, Cordero CL, Fullner Satchell KJ Autoprocessing of the Vibrio cholerae RTX toxin by the cysteine protease domain. EMBO J 2007, 26:2552-2561.
25. Egerer M, Giesemann T, Jank T, Satchell KJ, Aktories K Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on a cysteine protease activity. J Biol Chem 2007, 282:25314-25321.
26. Egerer M, Giesemann T, Herrmann C, Aktories K Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate. J Biol Chem 2009, 284:3389-3395.
27. Guttenberg G, Papatheodorou P, Genisyuerek S, Lu W, Jank T, Einsle O, et al. Inositol hexakisphosphate-dependent processing of Clostridium sordellii lethal toxin and Clostridium novyi alpha-toxin. J Biol Chem 2011, 286:14779-14786.
28. Pruitt RN, Chagot B, Cover M, Chazin WJ, Spiller B, Lacy DB Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A. J Biol Chem 2009, 284:21934-21940.
29. Shen A, Lupardus PJ, Gersch MM, Puri AW, Albrow VE, Garcia KC, et al. Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins. Nat Struct Mol Biol 2011, 18:364-371.
30. Just I, Selzer J, Wilm M, Von Eichel-Streiber C, Mann M, Aktories K Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995, 375:500-503.
31. Hofmann F, Busch C, Prepens U, Just I, Aktories K Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J Biol Chem 1997, 272:11074-11078.
32. Busch C, Hofmann F, Selzer J, Munro J, Jeckel D, Aktories K A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins. J Biol Chem 1998, 273:19566-19572.
33. Belyi Y, Tabakova I, Stahl M, Aktories K Lgt: a family of cytotoxic glucosyltransferases produced by Legionella pneumophila. J Bacteriol 2008, 190:3026-3035.
34. Reinert DJ, Jank T, Aktories K, Schulz GE Structural basis for the function of Clostridium difficile toxin B. J Mol Biol 2005, 351:973-981.
35. Ziegler MO, Jank T, Aktories K, Schulz GE Conformational changes and reaction of clostridial glycosylating toxins. J Mol Biol 2008, 377:1346-1356.
36. Pruitt RN, Chumbler NM, Rutherford SA, Farrow MA, Friedman DB, Spiller B, et al. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity. J Biol Chem 2012, 287:8013-8020.
37. D'Urzo N, Malito E, Biancucci M, Bottomley MJ, Maione D, Scarselli M, et al. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+and UDP provides insights into glucosyltransferase activity and product release. FEBS J 2012, 279:3085-3097.
38. Geissler B, Tungekar R, Satchell KJ Identification of a conserved membrane localization domain within numerous large bacterial protein toxins. Proc Natl Acad Sci USA 2010, 107:5581-5586.
39. Geissler B, Ahrens S, Satchell KJ Plasma membrane association of three classes of bacterial toxins is mediated by a basic-hydrophobic motif. Cell Microbiol 2012, 14:286-298.
40. Vetter IR, Hofmann F, Wohlgemuth S, Herrmann C, Just I Structural consequences of mono-glucosylation of Ha-Ras by Clostridium sordellii lethal toxin. J Mol Biol 2000, 301:1091-1095.
41. Geyer M, Wilde C, Selzer J, Aktories K, Kalbitzer HR Glucosylation of Ras by Clostridium sordellii lethal toxin: consequences for the effector loop conformations observed by NMR spectroscopy. Biochem 2003, 42:11951-11959.
42. Jank T, Ziegler MO, Schulz GE, Aktories K Inhibition of the glucosyltransferase activity of clostridial Rho/Ras-glucosylating toxins by castanospermine. FEBS Lett 2008, 582:2277-2282.
43. Jank T, Reinert DJ, Giesemann T, Schulz GE, Aktories K Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis. J Biol Chem 2005, 280:37833-37838.
44. Genth H, Pauillac S, Schelle I, Bouvet P, Bouchier C, Varela-Chavez C, et al. Haemorrhagic toxin and lethal toxin from Clostridium sordellii strain VPI9048: molecular characterization and comparative analysis of substrate specificity of the large clostridial glucosylating toxins. Cell Microbiol 2014, 16:1706-1721.
45. Just I, Wilm M, Selzer J, Rex G, Von Eichel-Streiber C, Mann M, et al. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 1995, 270:13932-13936.
46. Chaves-Olarte E, Weidmann M, Von Eichel-Streiber C, Thelestam M Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells. J Clin Invest 1997, 100:1734-1741.
47. Jank T, Giesemann T, Aktories K Clostridium difficile glucosyltransferase toxin B-Essential amino acids for substrate-binding. J Biol Chem 2007, 282:35222-35231.
48. Jank T, Pack U, Giesemann T, Schmidt G, Aktories K Exchange of a single amino acid switches the substrate properties of RhoA and RhoD towards glucosylating and transglutaminating toxins. J Biol Chem 2006, 281:19527-19535.
49. Pruitt RN, Chambers MG, Ng KK, Ohi MD, Lacy DB Structural organization of the functional domains of Clostridium difficile toxins A and B. Proc Natl Acad Sci USA 2010, 107:13467-13472.
50. Zhang Z, Park M, Tam J, Auger A, Beilhartz GL, Lacy DB, et al. Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore. Proc Natl Acad Sci USA 2014, 111:3721-3726.